Introduction
Diabetic coma without the characteristic features of Kussmaul respirations or acetone on the breath was reported many years ago (Frerichs, 1883; Stadelmann, 1883; Dreschfeld, 1886) , and case reports have appeared intermittently since that time (reviewed by Danowski and Nabarro, 1965; Schwartz and Apfelbaum, 1966) . Recently there has been much interest in "non-ketotic diabetic coma" and many attempts have been made to explain it (DiBenedetto et al., 1965; Henry and Bressler, 1968; Maccario and Messis, 1969 ; R. D. Johnson et al., 1969; Pyke, 1969; Spenney et al., 1969) .
The term "ketosis" was first used by Poulton (1918) to describe the specific metabolic acidosis which occurs in uncontrolled diabetes. Precise definition of ketosis should be made by reference to the level of blood ketone bodies, but their measurement has been complex and generally impracticable. The term "non-ketotic' has been carelessly used and in many instances refers to the absence of ketonuria (Danowski and Nabarro, 1965; Halmos et al., 1966) . This is not a reliable guide to the ketonaemia, which is better assessed by semiquantitative techniques such as the plasma sodium nitroprusside test using Ketostix (Watkins and FitzGerald, 1968) .
The present investigation was undertaken to measure blood ketone bodies in acute diabetic emergencies and to discover the relationship between blood glucose and ketonaemia. Serum insulin and plasma free fatty acids were measured to investigate why some patients develop severe hyperketonaemia and others do not. Diurnal changes of blood glucose, acetoacetates, and free fatty acids in poorly controlled but not ill diabetics were also examined to discover if there is any relationship between them. Recent developments of methods for determining blood ketone bodies by enzymatic (Williamson et al., 1962; Gibbard and Watkins, 1968) and automated (Salway, 1969) given by this method reflects its inaccuracy in this range on account of baseline drift that may occur during busy clinics. The reliability of the method above this level has been confirmed by comparison with the enzymatic method of Williamson et al. (1962) . Blood 3-hydroxybutyrate levels were measured by the method of Gibbard and Watkins (1968) , which is a modification of the enzymatic method of Williamson et al. (1962) . The normal fasting level is less than 0.3 mM (Antonis et al., 1966) and probably generally less than 0.1 mM (Jenkins et al., 1970; Williamson, personal communication) . Plasma free fatty acids were determined by the calorimetric method of Duncombe (1964) after Dole's (1956) extraction had been performed. The normal range is 0.45 to 0.90 mM (Henry, 1964) . Total fatty acids were measured by the method of Stern and Shapiro (1953) Fig. 1 . No other criteria were used in selection, so that a wide spectrum of ill diabetics could be included in the series. For convenience these patients are described as having "diabetic coma" and subdivided into those with ketoacidosis and non-ketotic patients according to whether or not the hyper- (Table I ) and a second series of 10 ketoacidotic patients are compared in Table II . The free fatty acids were raised in almost all the non-ketotic patients, and the levels were comparable to those in many of the ketoacidotics. The highest free fatty acid levels (greater than 2 mM) were, however, seen only in ketoacidosis.
Diurnal Changes in Inditidual Patients.-The studies shown in Figs. 2 and 3 demonstrate the interrelationship of blood glucose, acetoacetate, and plasma free fatty acids in two patients investigated under similar conditions. They had cos P.. Free Fatty Acids (mM) 0-8
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received their insulin on the previous day and had their last food at about 10 p.m. The blood glucose of these two patients increased to similar levels before insulin administration (360 and 320 mg./100 ml.), but the acetoacetate levels were very different (0.28 and 1.0 mM, respectively) (Fig. 2) . A further increase of the blood glucose in the first patient to 540 mg./100 ml. was accompanied by a maximum acetoacetate level of only 0-45 mM. Plasma free fatty acids in these patients (Fig. 3) increased to similar levels (1-6 and 1-5 mM respectively) whereas the acetoacetate concentrations were very different (0-28 and 1.0 mM). Willms et al., 1969) , though during a simple fast there appears to be an exponential relationship (Hanson et al., 1965) . The present investigations ( Johnson et al., 1969) . Their actual levels are not related. Thus though hepatic ketogenesis requires a supply of free fatty acids its rate is not solely determined by their plasma level (Start and Newsholme, 1968) . Mayes and Felts (1967) showed that oxidation of fatty acids is greater in livers taken from fasted rats than those from well-fed rats, and the hepatic glycogen content may to some extent regulate the rate of ketogenesis (Courtice and Douglas, 1936) . Moreover several of our non-ketotic patients were strongly hyperlipaemic, and both hypercholesterolaemia and hypertriglyceridaemia have been found in some patients (Table I) . Bewsher et al. (1970) made similar observations. The presence of sufficient circulating insulin might inhibit ketogenesis in patients with severe hyperglycaemia. Serum immunoreactive insulin in six non-ketotic patients before treatment ranged between 1 and 25 juu./ml. (Table I ). R. D. Johnson et al. (1969) described the case of a patient with serum insulin of 29 uu./ml., and lower values of 5 and 12
Au./ml. have been reported by Henry and Bressler (1968) . On the other hand, serum insulin levels of 5 to 33 Mu./ml. in five patients with diabetic ketosis were described by Pyke (1969) and are thus similar to those in the non-ketotic patients. Apparently small amounts of circulating insulin can suppress lipolysis (and therefore ketogenesis) without altering glucose uptake (Zierler and Rabinowitz, 1964) , thereby resulting in hyperglycaemia without hyperketonaemia. It remains uncertain why this occurs in some patients and not in others. Indirect evidence for the effective presence of insulin in non-ketotic patients exists, however, in that many of them prove to have mild diabetes which is easily controlled by diet alone or with oral therapy.
The role of diet in determining the rate of ketogenesis may be of considerable importance, and prolonged and very high carbohydrate intake could be one factor responsible for extreme hyperglycaemia with negligible hyperketonaemia. Mirsky et al. (1941) showed that administration of high carbohydrate diets to patients receiving only small amounts of insulin decrease ketonuria while simultaneously increasing blood glucose levels, while Soskin and Levine (1940) showed that tissue glucose uptake can sometimes occur in the absence of insulin if a sufficiently high blood glucose level is maintained. The absence of ketonuria in some West Indian diabetics has been attributed to the ingestion of large quantities of carbohydrate (Tulloch and MacIntosh, 1961) , and some "nonketotic diabetic coma" patients have been shown to have had a high carbohydrate intake (DiBenedetto et al., 1965) . It is of interest, therefore, that four of the nine non-ketotic patients reported here were West Indians. Carbohydrate intake in a series of new diabetics, however, did not seem to influence the level of the ketonaemia (Watkins et al., 1970, unpublished) .
Many other theories have been advanced to explain the low blood ketone levels in some patients, but none seem satisfactory. Thus, treatment with thiazide diuretics (Kumar, 1968; S0lvsteen et al., 1968; Tyler, 1968; Spenney et al., 1969) and hydantoinates (Goldberg and Sanbar, 1969) have been suggested. Jacobs and Nabarro (1969) showed that growth hormone and 1 1-hydroxycorticosteroid levels in non-ketotic cases are somewhat lower than in ketoacidosis. Moreover, ketoacidosis has been reported in a subject with hypopituitarism (Di Raimondo and Earll, 1968 
The nephrotoxicity of colistin has been a matter of controversy. In spite of reports of renal damage (Tallgren, Liewendahl, and Kuhlback, 1965 Though we were aware of the possible adverse effects of colistin on renal function, the failure to control the infection with conventional doses led us to increase the dosage sixfold to 26 mega units per day (10 mega units by intramuscular injection, 10 mega units by intravenous injection, and 6 mega units by aerosol inhalation). In the subsequent six-week period the incidence of klebsiella chest and urinary tract infections was halved.
Patients and Investigations
Fourteen patients aged 31 to 71 years (10 men and 4 women) were treated with high doses of colistin, each receiving 26 mega units per day. Four had a 15-day course, five between one and two weeks, and five less than a week. The mean length of treatment was 9-7 days. Five of these patients had cerebral abscesses, three had cerebral tumours, four had head injuries, and two had intracranial haemorrhage. Nine of the group were deeply unconscious and four required * Senior Registrar, Department of Neurosurgery.
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tracheostomy. Eight had klebsiella tracheobronchitis, one had klebsiella urinary tract infection, and five had both. During and after treatment eight patients died-one with a cerebral abscess, two with malignant tumours, three with head injuries, and two with intracranial haemorrhages. Six of the patients came to necropsy.
Sequential specimens of urine and sputum were examined bacteriologically and the urine was examined for casts. Serum and urine colistin levels, blood urea, serum creatinine, and creatinine clearance rates were determined at the onset of, during, and after treatment.
Results
Bacteriology.-The organism was eliminated from the sputu-n in 11 out of 13 patients within a week and from the uriie of six out of six patients in three days.
Renal Function Tests at Onset of Treatment.-Some patients were dehydrated, but within 24 hours of intravenous fluid therapy none had a blood urea above 45 mg./100 mL or a serum creatinine above 1.4 mg./100 ml.
Effects of Colistin on Renal Function.-In all patients a considerable fall in creatinine clearance and rises in both blood urea and serum creatinine levels were observed. Casts appeared in the urine of five patients during the course of treatment. In the six who survived the creatinine clearance rates serum creatinine, and blood urea returned to within normal limits. On the basis of these findings the patients seemed to fall into two categories. Category 1 (Fig. 1) comprised four patients whose creatinine clearance rate returned to the lower limits of normal within an average of three weeks (19, 30, 19 , and 20 days respectively. The graphs of Cases 1 and 4 show the expected rise in serum creatinine as the creatinine clearance rate falls. In Cases 2 and 3 this expected concurrent inverse relationship is not apparent at the time of the greatest reduction in creatinine clearance rate. This was presumably due to faulty collection of 24-hour urine specimens. Category
